“…This inhibitory mechanism involves the BRI1 KINASE INHIBITOR1 (BKI1), which binds to the kinase domain of unliganded BRI1 receptors and thereby keeps the LRR-RLK inactive (Jaillais et al, 2011b). In vitro, BKI1 precludes BRI1 from associating with BRI1-ASSOCIATED KINASE1 (BAK1; also known as SOMATIC EMBRYO-GENESIS RECEPTOR-LIKE KINASE3 [SERK3]; Wang and Chory, 2006;Jaillais et al, 2011b), another LRR-RLK required for BR signal transduction Nam and Li, 2002;Gou et al, 2012). Binding of BRs to the extracellular LRR domain of BRI1 homodimers is thought to result in conformational changes, which trigger basal BRI1 kinase activity and autophosphorylation Kim and Wang, 2010;Jaillais et al, 2011a).…”